Your browser doesn't support javascript.
loading
Effects of Omalizumab on FcεRI and IgE Expression in Lesional Skin of Bullous Pemphigoid.
Seyed Jafari, S Morteza; Gadaldi, Karolina; Feldmeyer, Laurence; Yawalkar, Nikhil; Borradori, Luca; Schlapbach, Christoph.
Afiliação
  • Seyed Jafari SM; Department of Dermatology, Inselspital-Bern University Hospital, University of Bern, Bern, Switzerland.
  • Gadaldi K; Department of Dermatology, Inselspital-Bern University Hospital, University of Bern, Bern, Switzerland.
  • Feldmeyer L; Department of Dermatology, Inselspital-Bern University Hospital, University of Bern, Bern, Switzerland.
  • Yawalkar N; Department of Dermatology, Inselspital-Bern University Hospital, University of Bern, Bern, Switzerland.
  • Borradori L; Department of Dermatology, Inselspital-Bern University Hospital, University of Bern, Bern, Switzerland.
  • Schlapbach C; Department of Dermatology, Inselspital-Bern University Hospital, University of Bern, Bern, Switzerland.
Front Immunol ; 10: 1919, 2019.
Article em En | MEDLINE | ID: mdl-31474990

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pele / Imunoglobulina E / Penfigoide Bolhoso / Receptores de IgE / Omalizumab Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pele / Imunoglobulina E / Penfigoide Bolhoso / Receptores de IgE / Omalizumab Idioma: En Ano de publicação: 2019 Tipo de documento: Article